SCHEMBL370765

SCHEMBL370765

Cc1cc(Cl)ccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(CO)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 3/20 0.38
FFAR1 O14842 3/20 0.37
MGAM O43451 2/20 0.35
GAA P10253 2/20 0.35
SI P14410 2/20 0.35
MGAM2 Q2M2H8 2/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KMT2A Q03164 2/20 0.34
CREBBP Q92793 1/20 0.34
PRKCZ Q05513 1/20 0.34
PPARG P37231 1/20 0.34
CXCR3 P49682 1/20 0.33
BRD4 O60885 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369581 0.91 POLB (0.40) CYP2C9CYP2C19POLBFFAR1MGAM
SCHEMBL371309 0.90 POLB (0.40) CYP2C9CYP2C19POLBFFAR1MGAM
SCHEMBL369928 0.89 CYP2C9 (0.39) CYP2C9CYP2C19POLBMGAMGAA
SCHEMBL15832896 0.89 POLB (0.39) CYP2C9CYP2C19POLBFFAR1MGAM
SCHEMBL369750 0.89 POLB (0.40) CYP2C9CYP2C19POLBFFAR1MGAM
SCHEMBL368816 0.89 KMT2A (0.46) CYP2C9CYP2C19POLBFFAR1MGAM
SCHEMBL368652 0.87 GPBAR1 (0.40) CYP2C9CYP2C19POLBFFAR1KEAP1
SCHEMBL368653 0.87 GPBAR1 (0.40) CYP2C9CYP2C19POLBFFAR1KEAP1
SCHEMBL368654 0.87 GPBAR1 (0.40) CYP2C9CYP2C19POLBFFAR1KEAP1
SCHEMBL1390419 0.87 LMNA (0.43) CYP2C9CYP2C19POLBFFAR1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103153945-B 1-oximino-3-phenyl-propanes HOFFMAN-LA ROCHE LTD. (CH) 2016-03-02 CN disclosed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
CN-103153945-A 1-oximino-3-phenyl-propanes HOFFMANN LA ROCHE 2013-06-12 CN disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 CYP2C9 1676/4885CYP2C19 1199/4885POLB 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.